Moneycontrol
HomeNewsBusinessEconomy'Mr. No, No, No' - Why Dutch PM Mark Rutte plays role of EU bogeyman

'Mr. No, No, No' - Why Dutch PM Mark Rutte plays role of EU bogeyman

Standing up for not spending money on European projects requires a naysayer, and Rutte has taken on the role with calculated determination as leader of a group of smaller 'frugal' nations.

July 20, 2020 / 16:29 IST
Story continues below Advertisement

As EU negotiations over a coronavirus recovery fund and a new budget for the bloc ran into an impasse, Netherlands Prime Minister Mark Rutte was singled out by one leader this weekend as the "man responsible for the whole mess".

Hungarian Prime Minister Viktor Orban accused him of that, while Spanish and Italian diplomats have taken to calling him "Mr. No No No!".

Story continues below Advertisement

Standing up for not spending money on European projects requires a naysayer, and Rutte has taken on the role with calculated determination as leader of a group of smaller "frugal" nations.

While he may cut a less colourful figure than Margaret Thatcher a generation ago, Rutte's readiness to don the mantle of parsimony after Britain's departure from the EU is solidly grounded in public opinion and politics at home.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show